{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Deuterated", "GS-441524", "SARS-CoV-2"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35844292", "DateRevised": {"Year": "2022", "Month": "12", "Day": "17"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "07", "Day": "09"}], "Language": ["eng"], "ELocationID": ["10.1016/j.tetlet.2022.154012"], "Journal": {"ISSN": "0040-4039", "JournalIssue": {"Volume": "104", "PubDate": {"Year": "2022", "Month": "Aug", "Day": "17"}}, "Title": "Tetrahedron letters", "ISOAbbreviation": "Tetrahedron Lett"}, "ArticleTitle": "Synthesis and anti-SARS-CoV-2 activity of deuterated GS-441524 analogs.", "Pagination": {"StartPage": "154012", "MedlinePgn": "154012"}, "Abstract": {"AbstractText": ["The COVID-19 caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is continuing to spread around the world. GS-441524 is the parent nucleoside of remdesivir which is the first drug approved for the treatment of COVID-19, and demonstrates strong activity against SARS-Cov-2 in vitro and in vivo. Herein, we reported the synthesis of a series of deuterated GS-441524 analogs, which had deuterium atoms up to five at the ribose and the nucleobase moieties. Compared to GS-441524, all the deuterated compounds showed similar inhibitory activities against SARS-CoV-2 in vitro."], "CopyrightInformation": "\u00a9 2022 Elsevier Ltd. All rights reserved."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, PR China."}, {"Identifier": [], "Affiliation": "University of Chinese Academy of Sciences, Beijing 100049, PR China."}], "LastName": "Zheng", "ForeName": "Wei", "Initials": "W"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory Basis of Xinjiang Indigenous Medicinal Plants Resource Utilization, Xinjiang Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, South Beijing Road 40-1, Urumqi 830011, PR China."}, {"Identifier": [], "Affiliation": "University of Chinese Academy of Sciences, Beijing 100049, PR China."}], "LastName": "Hu", "ForeName": "Tianwen", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, Hubei 430071, PR China."}], "LastName": "Zhang", "ForeName": "Yumin", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory Basis of Xinjiang Indigenous Medicinal Plants Resource Utilization, Xinjiang Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, South Beijing Road 40-1, Urumqi 830011, PR China."}, {"Identifier": [], "Affiliation": "University of Chinese Academy of Sciences, Beijing 100049, PR China."}], "LastName": "Wei", "ForeName": "Daibao", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Lingang Laboratory, Shanghai 200031, PR China."}], "LastName": "Xie", "ForeName": "Yuanchao", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, PR China."}, {"Identifier": [], "Affiliation": "University of Chinese Academy of Sciences, Beijing 100049, PR China."}], "LastName": "Shen", "ForeName": "Jingshan", "Initials": "J"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Tetrahedron Lett", "NlmUniqueID": "2984819R", "ISSNLinking": "0040-4039"}, "CoiStatement": "The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Sharma A., Tiwari S., Deb M.K., Marty J.L. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): a global pandemic and treatment strategies. Int. J. Antimicrob. Agents. 2020;56(2)", "ArticleIdList": ["PMC7286265", "32534188"]}, {"Citation": "Rubin D., Chan-Tack K., Farley J., Sherwat A. FDA approval of remdesivir \u2014 a step in the right direction. N. Engl. J. Med. 2020;383:2598\u20132600.", "ArticleIdList": ["33264539"]}, {"Citation": "Li Y., Cao L., Li G., Cong F., Li Y., Sun J., Luo Y., Chen G., Li G., Wang P., Xing F., Ji Y., Zhao J., Zhang Y., Guo D., Zhang X. Remdesivir metabolite GS-441524 effectively inhibits SARS-CoV-2 infection in mouse models. J. Med. Chem. 2022;65:2785\u20132793.", "ArticleIdList": ["33523654"]}, {"Citation": "Pruijssers A.J., George A.S., Sch\u00e4fer A., Leist S.R., Gralinksi L.E., Dinnon K.H., Yount B.L., Agostini M.L., Stevens L.J., Chappell J.D., Lu X., Hughes T.M., Gully K., Martinez D.R., Brown A.J., Graham R.L., Perry J.K., Du Pont V., Pitts J., Ma B., Babusis D., Murakami E., Feng J.Y., Bilello J.P., Porter D.P., Cihlar T., Baric R.S., Denison M.R., Sheahan T.P. Remdesivir Inhibits SARS-CoV-2 in human lung cells and chimeric SARS-CoV expressing the SARS-CoV-2 RNA polymerase in mice. Cell Rep. 2020;32:107940.", "ArticleIdList": ["PMC7340027", "32668216"]}, {"Citation": "Yan V.C., Muller F.L. Advantages of the parent nucleoside GS-441524 over remdesivir for covid-19 treatment. ACS Med. Chem. Lett. 2020;11:1361\u20131366.", "ArticleIdList": ["PMC7315846", "32665809"]}, {"Citation": "Xie J., Wang Z. Can remdesivir and its parent nucleoside GS-441524 be potential oral drugs? an in vitro and in vivo DMPK assessment. Acta Pharm. Sinica B. 2021;11:1607\u20131616.", "ArticleIdList": ["PMC8245906", "34221871"]}, {"Citation": "Gant T.G. Using deuterium in drug discovery: leaving the label in the drug. J. Med. Chem. 2014;57:3595\u20133611.", "ArticleIdList": ["24294889"]}, {"Citation": "Higashi T., Ogawa S. Isotope-coded ESI-enhancing derivatization reagents for differential analysis, quantification and profiling of metabolites in biological samples by LC/MS: A review. J. Pharm. Biomed. Anal. 2016;130:181\u2013193.", "ArticleIdList": ["27178301"]}, {"Citation": "Cargnin S., Serafini M., Pirali T. A primer of deuterium in drug design. Future Med. Chem. 2019;11:2039\u20132042.", "ArticleIdList": ["31538524"]}, {"Citation": "Pirali T., Serafini M., Cargnin S., Genazzani A.A. Applications of deuterium in medicinal chemistry. J. Med. Chem. 2019;62:5276\u20135297.", "ArticleIdList": ["30640460"]}, {"Citation": "Timmins G.S. Deuterated drugs: where are we now? Expert Opin. Ther. Pat. 2014;24:1067\u20131075.", "ArticleIdList": ["PMC4579527", "25069517"]}, {"Citation": "Xie Y., Yin W., Zhang Y., Shang W., Wang Z., Luan X., Tian G., Aisa H.A., Xu Y., Xiao G., Li J., Jiang H., Zhang S., Zhang L., Xu H.E., Shen J. Design and development of an oral remdesivir derivative VV116 against SARS-CoV-2. Cell Res. 2021;31:1212\u20131214.", "ArticleIdList": ["PMC8477624", "34584244"]}, {"Citation": "Qian H.-J., Wang Y., Zhang M.-Q., Xie Y.-C., Wu Q.-Q., Liang L.-Y., Cao Y., Duan H.-Q., Tian G.-H., Ma J., Zhang Z.-B., Li N., Jia J.-Y., Zhang J., Aisa H.A., Shen J.-S., Yu C., Jiang H.-L., Zhang W.-H., Wang Z., Liu G.-Y. Safety, tolerability, and pharmacokinetics of VV116, an oral nucleoside analog against SARS-CoV-2, in Chinese healthy subjects. Acta Pharmacol. Sin. 2022", "ArticleIdList": ["PMC8924727", "35296780"]}, {"Citation": "F\u00f6ldesi A., Chattopadhyaya J. Studies towards the large scale chemical synthesis of the precursors of ribonucleosides-3\u2032,4\u2032,5\u2032,5\u2033- 2H 4 and -2\u2032,3\u2032,4\u2032,5\u2032,5\u2033- 2H 5. Nucleosides Nucleotides Nucleic Acids. 2003;22:2093\u20132104.", "ArticleIdList": ["14714759"]}, {"Citation": "Xie Y., Hu T., Zhang Y., Wei D., Zheng W., Zhu F., Tian G., Aisa H.A., Shen J. Weinreb amide approach to the practical synthesis of a key remdesivir intermediate. J. Organic Chem. 2021;86:5065\u20135072.", "ArticleIdList": ["33733767"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "4", "Day": "11"}, {"Year": "2022", "Month": "7", "Day": "1"}, {"Year": "2022", "Month": "7", "Day": "6"}, {"Year": "2022", "Month": "7", "Day": "19", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "7", "Day": "19", "Hour": "6", "Minute": "1"}, {"Year": "2022", "Month": "7", "Day": "18", "Hour": "3", "Minute": "36"}, {"Year": "2022", "Month": "7", "Day": "9"}], "PublicationStatus": "ppublish", "ArticleIdList": ["35844292", "PMC9270844", "10.1016/j.tetlet.2022.154012", "S0040-4039(22)00456-7"]}}], "PubmedBookArticle": []}